Publication | Open Access

Conversion surgery after cetuximab or bevacizumab plus FOLFIRI chemotherapy in colorectal cancer patients with liver- and/or lung-limited metastases

Surgical OncologyGastrointestinal OncologyMedicineCancer ManagementConversion SurgeryColorectal CancerColorectal Cancer PatientsFolfiri ChemotherapySurgeryCancer TreatmentOncologyRadiation Oncology